A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1

Clinical trial NCT01247194 · COMPLETED

Trial details

NCT number: NCT01247194
Sponsor: Presidio Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Genotype 1 Hepatitis C Virus Infection

Start date: 2010-10-01
Primary completion: 2011-05-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.